Hereditary Breast and Ovarian Cancer Syndrome

Pediatric Reporting of Adult-Onset Genomic Results

Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention

Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations

The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI

Women at Risk of Breast Cancer and OLFM4

Development and Validation of an Ovarian Cancer Risk Prediction Model for Family Members of Ovarian Cancer Probands

Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199

Direct Information to At-risk Relatives

Enhance the Use of Genetic Counseling and Testing in Latinas

Impact of a Psychoeducational Intervention on Expectations and Coping in Young Women Exposed to a High HBOC Risk

Statewide Communication to Reach Diverse Low Income Women

Tissue Expansion in Breast Reconstruction Without Drains

Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries

Inherited Susceptible Genes Among Epithelial Ovarian Cancer

Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers

Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy

Risk-Reducing Surgeries for Hereditary Ovarian Cancer

Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study

Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer

Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers